TRML

Insider Trades

Name	Value	Action	Price	Current Price
Kulkarni Sandeep ChidambarDirector, Officer: CEO $26k1.8k shares BuyAug 21, 2024 $14.85 $47.98
Kulkarni Sandeep ChidambarDirector, Officer: CEO $72k5.2k shares BuyAug 16, 2024 $13.79 $47.98

Trade TRML

About Tourmaline Bio, Inc.

Tourmaline Bio, Inc. is a clinical-stage biotechnology firm committed to advancing therapies for individuals suffering from debilitating immune disorders. The company's development pipeline focuses on conditions such as Atherosclerotic Cardiovascular Disease (ASCVD) and Thyroid Eye Disease (TED). Established in 2021, this enterprise is headquartered in New York, New York.

CEO: Sandeep C. Kulkarni
IPO Date: May 7, 2021

Market Data

Open: $47.98
High: $47.98
Low: $47.98
Volume: 783.7K
Avg Volume: 925.8K
52W High: $48.27
52W Low: $11.56

Valuation

Market Cap: $1.2B
Enterprise Value: $1.2B
Dividend Yield: 0.00%

Financials

Free Cash Flow: -$77.3M
Revenue: $0
Net Income: -$73.2M
Cash: $30.5M
Debt: $244K

Events

EarningsNov 6

EPS est. -0.96 · actual -0.78